Skip to content

Effect of parenteral nutrition supplemented with ?-3 polyunsaturated fatty acids on postoperative recovery in elderly patients with colorectal cancer: a prospective multicenter randomized controlled study

Effect of parenteral nutrition supplemented with ?-3 polyunsaturated fatty acids on postoperative recovery in elderly patients with colorectal cancer: a prospective multicenter randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099172
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Experimental group:EN was initiated on the first postoperative day and SPN was received for at least 5 days until 80% of the energy target was achieved through EN or until discharge. EN products are r
Control group:EN was initiated on the first postoperative day and SPN was received for at least 5 days until 80% of the energy target was achieved through EN or until discharge. Postoperative enteral

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically confirmed colorectal cancer undergoing surgery; 2. Age >=60 years old, male or female; 3. Have not received any anti-tumor treatment for rectal cancer, including radiotherapy, chemotherapy, surgery, etc. 4. ECOG PS 0-1; 5. Normal function of major organs; 6. Signed written informed consent and volunteered to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Preoperative nutritional support with ?-3PUFA; 2. Preoperative parenteral nutrition; 3. Infection existed before surgery; 4. Abnormal liver function; 5. Renal dysfunction; 6. Unstable vital signs or hemodynamic parameters; 7. Systemic lupus erythematosus; 8. Type I diabetes mellitus; 9. Hyperthyroidism; 10.Have participated in other clinical research; 11. According to the investigator's judgment, there are other factors that may lead to the forced termination of the study, such as other serious diseases (including mental diseases) requiring combined treatment, alcohol abuse, drug abuse, family or social factors, and factors that may affect the safety or compliance of the subjects.

Design outcomes

Primary

MeasureTime frame
Pulmonary infection;Intestinal infection;Urinary tract infection;Incision infection;Interleukin-6;

Secondary

MeasureTime frame
Blood routine test markers;C-reactive protein;Procalcitonin;Liver function;Renal function;Lipid ;T lymphocyte subsets in peripheral blood;Fecal microbiota;Quality of life score within 1 month after surgery;Mortality within 3 months after surgery;

Countries

China

Contacts

Public ContactJianping Zhou

The First Hospital of China Medical University

zjphama@163.com+86 138 4050 9519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026